Benjamin Edwards Inc’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-12,075
Closed -$812K 1329
2025
Q3
$812K Sell
12,075
-85
-0.7% -$6.73K 0.01% 765
2025
Q2
$1.06M Sell
12,160
-1,238
-9% -$97K 0.01% 610
2025
Q1
$915K Buy
13,398
+1,344
+11% +$110K 0.01% 603
2024
Q4
$937K Buy
12,054
+2,328
+24% +$172K 0.01% 628
2024
Q3
$652K Buy
+9,726
New +$799K 0.01% 713

Other funds holding DXCM

Benjamin Edwards Inc's DXCM Position: Q4 2025 in Review

Benjamin Edwards Inc sold out of DexCom (DXCM) in Q4 2025, closing a stake of 12,075 shares — an estimated $812K sold.

Benjamin Edwards Inc first reported a position in DXCM in Q3 2024 and held it in 5 quarters. The position peaked at $1.06M in Q2 2025. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Benjamin Edwards Inc reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Benjamin Edwards Inc sold 12,075 DexCom shares in Q4 2025, an estimated $812K.
  • Benjamin Edwards Inc first reported a position in DexCom in Q3 2024 and held it in 5 quarters.
  • Benjamin Edwards Inc's DexCom position peaked at $1.06M in Q2 2025.
  • 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Benjamin Edwards Inc's 13F filing for Q4 2025, filed 2 Feb 2026.